THERAPEUTIC MONITORING OF ANTI-ARRHYTHMIC DRUGS

被引：18

作者：

KATES, RE

机构：

来源：

关键词：

D O I：

10.1097/00007691-198004000-00002

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

引用

页码：119 / 126

页数：8

共 55 条

[1]

ARNOLD K, 1970, CLIN PHARMACOL THER, V11, P121

[2]

ATKINSON AJ, 1977, CLIN PHARMACOL THER, V21, P575

[3]

BECKETT AH, 1977, POSTGRAD MED J, V53, P60

BIGGER, JT ;

SCHMIDT, DH ;

KUTT, H .

[5]

Brodie BB, 1943, J PHARMACOL EXP THER, V78, P154

[6]

BROEKHUYSEN J, 1969, ARCH INT PHARMACOD T, V177, P340

[7] ANTI-ARRHYTHMIC EFFECTS OF LIDOCAINE METABOLITES [J].

BURNEY, RG ;

DIFAZIO, CA ;

PEACH, MJ ;

PETRIE, KA ;

SILVESTER, MJ .

[8]

CAMPBELL NPS, 1978, BRIT J CLIN PHARMACO, V6, P103, DOI 10.1111/j.1365-2125.1978.tb00833.x

[9]

COLLINSWORTH KA, 1975, CLIN PHARMACOL THER, V18, P59

[10]

CONARD GJ, 1979, CLIN PHARMACOL THER, V25, P218